GlobeNewswire Inc.··Relay TherapeuticsRelay Therapeutics Advances Breast Cancer Drug Combo Toward Phase 3 Trial
Relay Therapeutics reports positive Phase 2 data for zovegalisib triplet combination in metastatic breast cancer, planning Phase 3 launch in early 2027.
PFERLAYPhase 3 trialzovegalisib